{"id":106361,"date":"2023-08-07T18:37:49","date_gmt":"2023-08-07T13:07:49","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=106361"},"modified":"2023-08-07T18:37:50","modified_gmt":"2023-08-07T13:07:50","slug":"ipo-update-concord-biotech-subscribed-2x-on-day-2","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-subscribed-2x-on-day-2\/","title":{"rendered":"IPO Update: Concord Biotech Subscribed 2x on Day 2"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-611300542\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>The initial public offer of Concord Biotech was subscribed 2.03 times on the second day on Monday. Kotak Mahindra Capital Company, Citigroup Global Markets India and Jefferies India are the managers to the offer.<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-1985846955\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p>The Rs 1,550.59-crore public offering received bids for 2,34,03,680 shares against 1,15,13,609 shares on offer, according to NSE data. The portion for non-institutional investors was subscribed 5.21 times while the category for Retail Individual Investors (RIIs) got 2.25 times subscription. The quota for Qualified Institutional Buyers (QIBs) got subscribed 1.61 times.<\/p><p>The Initial Public Offer (IPO) of 2,09,25,652 equity shares is in a price range of Rs 705-741 a share. The IPO of the Ahmedabad-based company is entirely an Offer For Sale (OFS). Rare Enterprises-backed Concord Biotech on Thursday said it collected Rs 465 crore from anchor investors.<\/p><p>Concord is among leading manufacturers of fermentation-based biopharmaceutical active pharmaceutical ingredients (API), focused on niche segments such as immunosuppressant, oncology, antifungal and antibacterial. The company, which currently has 23 API products, has three manufacturing facilities at Valthera, Dholka, and Limbasi, in Gujarat.<\/p><div class=\"trade-content_5\" id=\"trade-1584038764\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><div class=\"trade-after-content\" id=\"trade-740261946\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>The initial public offer of Concord Biotech was subscribed 2.03 times on the second day on Monday. Kotak Mahindra Capital Company, Citigroup Global Markets India and Jefferies India are the managers to the offer. The Rs 1,550.59-crore public offering received bids for 2,34,03,680 shares against 1,15,13,609 shares on offer, according to NSE data. The portion [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":17570,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[1696,31],"tags":[],"class_list":["post-106361","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-corporate-action","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>IPO Update: Concord Biotech Subscribed 2x on Day 2 - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"The initial public offer of Concord Biotech was subscribed 2.03 times on the second day on Monday. Kotak Mahindra Capital Company, Citigroup Global Markets India and Jefferies India are the managers to the offer.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-subscribed-2x-on-day-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IPO Update: Concord Biotech Subscribed 2x on Day 2\" \/>\n<meta property=\"og:description\" content=\"The initial public offer of Concord Biotech was subscribed 2.03 times on the second day on Monday. Kotak Mahindra Capital Company, Citigroup Global Markets India and Jefferies India are the managers to the offer.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-subscribed-2x-on-day-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-07T13:07:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-07T13:07:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/01\/IPO-Cover-Image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-subscribed-2x-on-day-2\/\",\"url\":\"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-subscribed-2x-on-day-2\/\",\"name\":\"IPO Update: Concord Biotech Subscribed 2x on Day 2 - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-subscribed-2x-on-day-2\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-subscribed-2x-on-day-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/01\/IPO-Cover-Image.jpg\",\"datePublished\":\"2023-08-07T13:07:49+00:00\",\"dateModified\":\"2023-08-07T13:07:50+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"The initial public offer of Concord Biotech was subscribed 2.03 times on the second day on Monday. Kotak Mahindra Capital Company, Citigroup Global Markets India and Jefferies India are the managers to the offer.\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-subscribed-2x-on-day-2\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-subscribed-2x-on-day-2\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-subscribed-2x-on-day-2\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/01\/IPO-Cover-Image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/01\/IPO-Cover-Image.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-subscribed-2x-on-day-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IPO Update: Concord Biotech Subscribed 2x on Day 2\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"IPO Update: Concord Biotech Subscribed 2x on Day 2 - Trade Brains Features","description":"The initial public offer of Concord Biotech was subscribed 2.03 times on the second day on Monday. Kotak Mahindra Capital Company, Citigroup Global Markets India and Jefferies India are the managers to the offer.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-subscribed-2x-on-day-2\/","og_locale":"en_US","og_type":"article","og_title":"IPO Update: Concord Biotech Subscribed 2x on Day 2","og_description":"The initial public offer of Concord Biotech was subscribed 2.03 times on the second day on Monday. Kotak Mahindra Capital Company, Citigroup Global Markets India and Jefferies India are the managers to the offer.","og_url":"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-subscribed-2x-on-day-2\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2023-08-07T13:07:49+00:00","article_modified_time":"2023-08-07T13:07:50+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/01\/IPO-Cover-Image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-subscribed-2x-on-day-2\/","url":"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-subscribed-2x-on-day-2\/","name":"IPO Update: Concord Biotech Subscribed 2x on Day 2 - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-subscribed-2x-on-day-2\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-subscribed-2x-on-day-2\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/01\/IPO-Cover-Image.jpg","datePublished":"2023-08-07T13:07:49+00:00","dateModified":"2023-08-07T13:07:50+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"The initial public offer of Concord Biotech was subscribed 2.03 times on the second day on Monday. Kotak Mahindra Capital Company, Citigroup Global Markets India and Jefferies India are the managers to the offer.","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-subscribed-2x-on-day-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-subscribed-2x-on-day-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-subscribed-2x-on-day-2\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/01\/IPO-Cover-Image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/01\/IPO-Cover-Image.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-subscribed-2x-on-day-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"IPO Update: Concord Biotech Subscribed 2x on Day 2"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/106361","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=106361"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/106361\/revisions"}],"predecessor-version":[{"id":106362,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/106361\/revisions\/106362"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/17570"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=106361"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=106361"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=106361"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}